Skip to content
hepatitis A vaccine

File:Havrix_junior_mondose_(hepatitis_A).jpg · Wikimedia Commons · See Wikimedia Commons

EntityQ3553093· pop 46· linked from 435 articles

hepatitis A vaccine

Sign in to save

Also known as hepatitis A vaccines

vaccine to prevent Hepatitis A

Key facts

Target
Hepatitis A virus
Vaccine type
Inactivated or attenuated
Trade names
Havrix, others
Ahfs drugs com
Monograph
Medlineplus
a695003
Pregnancy category
Australia</span>"}]]}'>AU : B2
Routes of administration
Intramuscular
Atc code
J07BC02 ( WHO )
Legal status
Australia</span>"}]]}'>AU : S4 (Prescription only) United States</span>"}]]}'>US : ℞-only European Union</span>"}]]}'>EU : Rx-only In general: ℞ (Prescription only)
Drugbank
DB10989
Chemspider
none
Unii
G54MT8V18G

via Wikipedia infobox

Research

2,284 papers

via PubMed

Wikidata facts

Image
Twinrix GlaxoSmithKline - i-hepA & r-hepB-S-Ag - doos Terumo-naald spuiten.JPG
Show 4 more facts
Sources (3)

via Wikidata · CC0

~7 min read

Encyclopedic overview

Hepatitis A vaccine is a vaccine that prevents hepatitis A. It is effective in around 95% of cases and lasts for at least twenty years and possibly a person's entire life. If given, two doses are recommended beginning after the age of one. It is given by injection into a muscle. The first hepatitis A vaccine was approved in the European Union in 1991, and the United States in 1995. It is on the World Health Organization's List of Essential Medicines.

The World Health Organization (WHO) recommends universal vaccination in areas where the disease is moderately common. Where the disease is very common, widespread vaccination is not recommended as people typically develop immunity through infection during childhood. The US Centers for Disease Control and Prevention (CDC) recommends vaccinating:

Excerpted from Wikipedia’s “hepatitis A vaccine” article, available under the CC BY-SA 4.0 licence.

Gallery (2)